BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 20464745)

  • 1. Prostaglandin E1 for preventing the progression of diabetic kidney disease.
    Wang H; Deng JL; Yue J; Li J; Hou YB
    Cochrane Database Syst Rev; 2010 May; (5):CD006872. PubMed ID: 20464745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline for diabetic kidney disease.
    Shan D; Wu HM; Yuan QY; Li J; Zhou RL; Liu GJ
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006800. PubMed ID: 22336824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin B and its derivatives for diabetic kidney disease.
    Raval AD; Thakker D; Rangoonwala AN; Gor D; Walia R
    Cochrane Database Syst Rev; 2015 Jan; 1():CD009403. PubMed ID: 25579852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese herbal medicine for diabetic kidney disease: a systematic review and meta-analysis of randomised placebo-controlled trials.
    Zhang L; Yang L; Shergis J; Zhang L; Zhang AL; Guo X; Qin X; Johnson D; Liu X; Lu C; Xue CC; Mao W
    BMJ Open; 2019 May; 9(4):e025653. PubMed ID: 31048437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein restriction for diabetic kidney disease.
    Jiang S; Fang J; Li W
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014906. PubMed ID: 36594428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education programmes for people with diabetic kidney disease.
    Li T; Wu HM; Wang F; Huang CQ; Yang M; Dong BR; Liu GJ
    Cochrane Database Syst Rev; 2011 Jun; (6):CD007374. PubMed ID: 21678365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive agents for preventing diabetic kidney disease.
    Lv J; Perkovic V; Foote CV; Craig ME; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2012 Dec; 12():CD004136. PubMed ID: 23235603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral adsorbents for preventing or delaying the progression of chronic kidney disease.
    Wu HM; Sun HJ; Wang F; Yang M; Dong BR; Liu GJ
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007861. PubMed ID: 25317905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial.
    Jin D; Huang WJ; Meng X; Yang F; Bao Q; Zhang MZ; Yang YN; Ni Q; Lian FM; Tong XL
    Trials; 2019 Dec; 20(1):756. PubMed ID: 31864393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic effect and possible harm of puerarin for treatment of stage III diabetic nephropathy: a meta-analysis.
    Wang B; Chen S; Yan X; Li M; Li D; Lv P; Ti G
    Altern Ther Health Med; 2015; 21(1):36-44. PubMed ID: 25599431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial.
    Li P; Chen Y; Liu J; Hong J; Deng Y; Yang F; Jin X; Gao J; Li J; Fang H; Liu G; Shi L; Du J; Li Y; Yan M; Wen Y; Yang W
    PLoS One; 2015; 10(5):e0126027. PubMed ID: 25938778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.
    Zhang HW; Lin ZX; Xu C; Leung C; Chan LS
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008369. PubMed ID: 25335553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
    Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and related substances for preventing diabetic kidney disease.
    Li J; Wu HM; Zhang L; Zhu B; Dong BR
    Cochrane Database Syst Rev; 2010 Sep; (9):CD005631. PubMed ID: 20824845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.
    Yan M; Wen Y; Yang L; Wu X; Lu X; Zhang B; Huang W; Li P
    Trials; 2016 May; 17(1):259. PubMed ID: 27216240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E1 for treatment of erectile dysfunction.
    Urciuoli R; Cantisani TA; Carlini M; Giuglietti M; Botti FM
    Cochrane Database Syst Rev; 2004; (2):CD001784. PubMed ID: 15106162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone antagonists for preventing the progression of chronic kidney disease.
    Navaneethan SD; Nigwekar SU; Sehgal AR; Strippoli GF
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007004. PubMed ID: 19588415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormones for acute kidney injury.
    Nigwekar SU; Strippoli GF; Navaneethan SD
    Cochrane Database Syst Rev; 2013 Jan; (1):CD006740. PubMed ID: 23440810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.